Julia Bonavitacola

Treatment Combinations Based in Immune Checkpoint Inhibitors Provide Survival Benefits in CRC

Treatment combinations based on immune checkpoint inhibitors (ICI) provided survival benefits for patients with heavily pretreated microsatellite stable (MSS) metastatic colorectal cancer (mCRC), according to a study published in the American Journal of Cancer Research.1 The treatment was found to

Treatment Combinations Based in Immune Checkpoint Inhibitors Provide Survival Benefits in CRC Read More »